AJP - Heart and Circulatory Physiology, Vol 273, Issue 3 1177-H1186, Copyright © 1997 by American Physiological Society

ARTICLES

Role of sympathetic nervous system in cardiovascular effects of centrally administered endothelin-1 in rats

A. Gulati, S. Rebello and A. Kumar
Department of Pharmaceutics and Pharmacodynamics, University of Illinois at Chicago 60612-7231, USA.

Centrally administered endothelin-1 (ET-1) produces a biphasic response, an initial increase followed by a decrease in blood pressure (BP). The pressor effect is due to stimulation of the sympathetic nervous system and/or release of vasopressin. The mechanism responsible for the depressor effect after central administration of ET-1 is still not known. Systemic and regional circulatory effects of intracerebroventricular (i.c.v.) administration of ET-1 (100 ng) were determined in anesthetized rats, using a radioactive microsphere technique. BP, cardiac output, and stroke volume were significantly decreased 30, 60, and 120 min after central administration of ET-1. Heart rate and total peripheral resistance were not altered. ET-1 produced a reduction in blood flow to the brain (83%), heart (62%), kidneys (53%), gastrointestinal tract (43%), portal system (46%), and musculoskeletal system (55%). To determine the role of the central nervous system in cardiovascular effects of centrally administered ET-1, experiments were performed in cervical-sectioned rats. The changes in systemic and regional blood circulation induced by centrally administered ET-1 in normal rats were not observed in cervical-sectioned rats. Pretreatment with a specific antagonist of ETA receptors, BQ-123 (10 micrograms i.c.v.), antagonized systemic and regional circulatory effects of ET-1. Centrally administered clonidine (1 microgram i.c.v.) produced hypotension and bradycardia, known to be mediated through the sympathetic nervous system. Pretreatment with an ETA receptor antagonist, BMS-182874 (50 micrograms/kg iv), blocked clonidine-induced hypotension and bradycardia. We conclude that centrally administered ET-1 stimulates ETA receptors to produce systemic and regional circulatory changes mediated by the sympathetic nervous system.

This article has been cited by other articles:

				G. Perfume, S. L. Nabhen, K. Riquelme Barrera, M. G. Otero, L. G. Bianciotti, and M. S. Vatta Long-term modulation of tyrosine hydroxylase activity and expression by endothelin-1 and -3 in the rat anterior and posterior hypothalamus Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2008; 294(3): R905 - R914. [Abstract] [Full Text] [PDF]

				J. ANTUNES-RODRIGUES, M. DE CASTRO, L. L. K. ELIAS, M. M. VALENCA, and S. M. McCANN Neuroendocrine Control of Body Fluid Metabolism Physiol Rev, January 1, 2004; 84(1): 169 - 208. [Abstract] [Full Text] [PDF]

				A. W. C. Yip and T. L. Krukoff Endothelin-A receptors and NO mediate decrease in arterial pressure during recovery from restraint Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2002; 282(3): R881 - R889. [Abstract] [Full Text] [PDF]

				J.-L. Liu, R. U. Pliquett, E. Brewer, K. G. Cornish, Y.-T. Shen, and I. H. Zucker Chronic endothelin-1 blockade reduces sympathetic nerve activity in rabbits with heart failure Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1906 - R1913. [Abstract] [Full Text] [PDF]

				N. F. Rossi and H. Chen PVN lesions prevent the endothelin 1-induced increase in arterial pressure and vasopressin Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E349 - E356. [Abstract] [Full Text] [PDF]

				N. F. Rossi, D. S. O'Leary, D. Woodbury, and H. Chen Endothelin-1 in hypertension in the baroreflex-intact SHR: a role independent from vasopressin release Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E18 - E24. [Abstract] [Full Text] [PDF]

				E. L. Schiffrin Role of Endothelin-1 in Hypertension Hypertension, October 1, 1999; 34(4): 876 - 881. [Abstract] [Full Text] [PDF]

				M. Shihara, Y. Hirooka, N. Hori, I. Matsuo, T. Tagawa, S. Suzuki, N. Akaike, and A. Takeshita Endothelin-1 increases the neuronal activity and augments the responses to glutamate in the NTS Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R658 - R665. [Abstract] [Full Text] [PDF]